felbamate 600 MG in 5 mL Oral Suspension
- RxCUI
- 310285
- RxNorm name
- felbamate 600 MG in 5 mL Oral Suspension
- Display name
- felbamate 600 MG in 5 mL Oral Suspension
- Full name
- felbamate 600 MG in 5 mL Oral Suspension
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Felbamate | FELBAMATE | Sun Pharmaceutical Industries, Inc. | 0afffb17-e6ac-4bea-a90e-7ef3c8150290 | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | 310285 |
| Felbatol | FELBAMATE | Viatris Specialty LLC | 2f522701-397a-11de-8a39-0800200c9a66 | 2025-08-15 | Boxed warning, Warnings, Adverse reactions | 310285 |
| Felbamate | FELBAMATE | Amneal Pharmaceuticals LLC | 2e325d79-d0a4-4af7-b09b-96ee5a5b2a37 | 2024-10-24 | Boxed warning, Warnings, Adverse reactions | 310285 |
| Felbamate | FELBAMATE | Novitium Pharma LLC | 81c8a2e1-732c-4467-84e9-53fef1655ee2 | 2022-09-13 | Boxed warning, Warnings, Adverse reactions | 310285 |
| Felbamate | FELBAMATE | NORTHSTAR RX LLC | 556de35d-3b98-48d3-a670-50e9d93437a4 | 2018-04-17 | Boxed warning, Warnings, Adverse reactions | 310285 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2f522701-397a-11de-8a39-0800200c9a66 | felbamate 600 MG in 5 mL Oral Suspension [PSN] · felbamate 120 MG/ML Oral Suspension [SCD] · felbamate 600 MG per 5 ML Oral Suspension [SY] · FELT 120 MG/ML Oral Suspension [SY] | 4 | 16 | Before Prescribing Felbatol® (felbamate), the physician should be thoroughly familiar with the details of this prescribing information. FELBATOL® SHOULD NOT BE USED BY PATIENTS UNTIL THERE HAS BEEN A COMPLETE DISCUSSION OF THE RISKS AND THE PATIENT, PARENT, OR GUARDIAN HAS BEEN PROVIDED THE FELBATOL WRITTEN ACKNOWLEDGEMENT (SEE PATIENT/PHYSICIAN ACKNOWLEDGMENT FORM). | 20250815 |
| 2e325d79-d0a4-4af7-b09b-96ee5a5b2a37 | felbamate 600 MG in 5 mL Oral Suspension [PSN] · felbamate 120 MG/ML Oral Suspension [SCD] · felbamate 600 MG per 5 ML Oral Suspension [SY] · FELT 120 MG/ML Oral Suspension [SY] | 4 | 14 | Felbamate Oral Suspension, USP 600 mg/5 mL Rx Only | 20241024 |
| 0afffb17-e6ac-4bea-a90e-7ef3c8150290 | felbamate 600 MG in 5 mL Oral Suspension [PSN] · felbamate 120 MG/ML Oral Suspension [SCD] · felbamate 600 MG per 5 ML Oral Suspension [SY] · FELT 120 MG/ML Oral Suspension [SY] | 4 | 3 | Felbamate Oral Suspension USP 600 mg/5 mL | 20170621 |
| 81c8a2e1-732c-4467-84e9-53fef1655ee2 | felbamate 600 MG in 5 mL Oral Suspension [PSN] · felbamate 120 MG/ML Oral Suspension [SCD] · felbamate 600 MG per 5 ML Oral Suspension [SY] · FELT 120 MG/ML Oral Suspension [SY] | 4 | 2 | Felbamate Oral Suspension, USP 600 mg/5 mL | 20220913 |
| 556de35d-3b98-48d3-a670-50e9d93437a4 | felbamate 600 MG in 5 mL Oral Suspension [PSN] · felbamate 120 MG/ML Oral Suspension [SCD] · felbamate 600 MG per 5 ML Oral Suspension [SY] · FELT 120 MG/ML Oral Suspension [SY] | 4 | 1 | Felbamate Oral Suspension USP | 20180417 |